An overview of clinical and commercial impact of drug delivery systems
about
Influence of physical properties of carrier on the performance of dry powder inhalersTransdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and ChallengesEmerging therapeutic delivery capabilities and challenges utilizing enzyme/protein packaged bacterial vesiclesProtein aggregation and its impact on product qualityNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cellsBiomedical Imaging in Implantable Drug Delivery Systems.Long-Term Prophylaxis and Pharmacokinetic Evaluation of Intramuscular Nano- and Microparticle Decoquinate in Mice Infected with P. berghei Sporozoites.Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancerLow-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model.A Review of Clinical Translation of Inorganic Nanoparticles.Responsive Hydrogel Nanoparticles for Pulmonary Delivery.Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cellsControl of polymeric nanoparticle size to improve therapeutic delivery.Production methods and stabilization strategies for polymer-based nanoparticles and microparticles for parenteral delivery of peptides and proteins.Therapeutic and safety considerations of nanoparticle-mediated drug delivery in pregnancy.Overcoming T. gondii infection and intracellular protein nanocapsules as biomaterials for ultrasonically controlled drug release.Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer.Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.Incorporation of VSV-G produces fusogenic plasma membrane vesicles capable of efficient transfer of bioactive macromolecules and mitochondria.DNA nanomaterials for preclinical imaging and drug deliveryPDZ Domain in the Engineering and Production of a Saporin Chimeric Toxin as a Tool for targeting Cancer Cells.Materials Chemistry of Nanoultrasonic Biomedicine.Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.Single-walled carbon nanotube-loaded doxorubicin and Gd-DTPA for targeted drug delivery and magnetic resonance imaging.New perspectives in nanotherapeutics for chronic respiratory diseases.Newer drug delivery systems in anesthesia.Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles.Application of dual targeting drug delivery system for the improvement of anti-glioma efficacy of doxorubicin.Enhanced epidermal localization of topically applied steroids using SPACE™ peptide.Insulin-loaded PLGA microspheres for glucose-responsive release.Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers.Creation of a long-acting nanoformulated dolutegravir.A Smart Nano-Prodrug Platform with Reactive Drug Loading, Superb Stability, and Fast Responsive Drug Release for Targeted Cancer Therapy.Antibacterial active open-porous hydroxyapatite/lysozyme scaffolds suitable as bone graft and depot for localised drug delivery.Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.An injectable drug-loaded hydrogel based on a supramolecular polymeric prodrug.Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.
P2860
Q26740570-25986F2A-191B-4AF4-9A74-A950FF60D32DQ26778469-4C60444B-6DD8-42D5-8AA9-C364C1C95EF2Q26798105-58D9BDE5-72BF-4E52-A4BD-A86334F8274BQ26801293-14CE8773-50E0-4DB1-A27A-3A9C0B932181Q27010661-38E824C2-7164-4B66-9ABC-0B8DBFFF4A1EQ28078448-9EC51740-DCB7-4CB5-8D76-D1976CF73FDFQ30376445-557BA89B-5F6F-43BB-A759-977A299605EAQ30394673-8E0E9689-98A6-4962-A7C9-0A9078A1DA89Q33607991-D8F4282A-F134-45DF-BA8F-2B442CFFB495Q33881254-B1EC818D-9CFC-4E35-B956-4771143F7FC6Q35181613-5E1EEB6B-C964-4837-A23E-7B551FC46DA9Q35884898-1ACE5393-7BF6-4F4B-9072-740525898A78Q35967907-3D90AB97-1760-4B58-A95E-A148D4B9D8FDQ36007934-B34C5FF2-667D-47E3-8E10-2DE9352661D1Q36130906-FB078D33-F9FE-443A-A2FD-D95360F6AB6CQ36307555-C85BB101-C0BC-42B5-BA76-B254C8C4BAC3Q38324367-1A79457E-9694-4B9B-A857-FEC660D43FD8Q38555085-211404F7-212A-4B71-8B4D-23E5CD603C0CQ38641476-FB0C2F09-4C31-49F3-B8CF-721B829EA5E6Q38665015-D091CC5F-AEE4-459F-BBD0-E5EFBAAB7E05Q38760096-2EB746E3-D59D-4149-9006-ED8D80CF96BFQ38771915-38FEDA7B-1499-496D-8ECB-5CB1CCF60C52Q38831073-883FC904-0416-4376-9753-A2FEDC9E941DQ38920708-4ECCFC15-5C3C-4400-9A51-7D17CF77F567Q39043064-49E439E1-1FCA-4E74-B6FF-94079E43333CQ39371494-87894CF0-5981-4795-A70C-CDC786A8935BQ39515155-C02F01A7-371E-4745-8D9F-99D39318DB1FQ40039105-AE6A0084-3182-48ED-86FA-BF4F987A5B0EQ41081606-FDD8B34A-4128-400B-9419-273C8729B1D1Q41152019-BE01AC3A-0E0E-4D4F-95F2-1A0B44972770Q41709059-D82B49E6-D334-4B62-B30E-C319382D3CFBQ46736498-B0C55A1E-3B22-40FB-A75C-FF236BCE39EEQ47603482-94C0FC9D-04C4-4297-9B70-EEE9158479A2Q49560705-755305B9-D06C-4DD5-BE29-C40347652A1CQ50051618-58FC83D1-59AB-4428-8818-2DDF6CB3400BQ50681917-318A878A-3190-44F0-ADDF-7FA2239D5ACFQ50935072-E77BCB5D-F491-403C-BDF7-3F40B336862DQ50951031-1A06FEBC-4CB4-4ED7-A959-7853CBC2BD24Q51802135-4F4B8323-F694-44C0-B859-559D83F98BA2Q54978120-E819A9E0-553F-42CE-A747-1583FD9F1C97
P2860
An overview of clinical and commercial impact of drug delivery systems
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An overview of clinical and commercial impact of drug delivery systems
@ast
An overview of clinical and commercial impact of drug delivery systems
@en
An overview of clinical and commercial impact of drug delivery systems
@nl
type
label
An overview of clinical and commercial impact of drug delivery systems
@ast
An overview of clinical and commercial impact of drug delivery systems
@en
An overview of clinical and commercial impact of drug delivery systems
@nl
prefLabel
An overview of clinical and commercial impact of drug delivery systems
@ast
An overview of clinical and commercial impact of drug delivery systems
@en
An overview of clinical and commercial impact of drug delivery systems
@nl
P2860
P3181
P1476
An overview of clinical and commercial impact of drug delivery systems
@en
P2093
Samir Mitragotri
P2860
P3181
P356
10.1016/J.JCONREL.2014.03.053
P407
P577
2014-04-18T00:00:00Z